TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA WITH CISPLATIN

被引:18
作者
LAD, TE
MISHOULAM, HM
SHEVRIN, DH
KUKLA, LJ
ABRAMSON, EC
KUKREJA, SC
机构
[1] VET ADM W SIDE MED CTR,DEPT MED,ENDOCRINOL SECT,CHICAGO,IL 60680
[2] UNIV ILLINOIS HOSP,COLL MED,CHICAGO,IL 60612
关键词
D O I
10.1001/archinte.147.2.329
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:329 / 332
页数:4
相关论文
共 19 条
[1]  
CHANG J, 1985, CLIN RES, V33, pA888
[2]  
EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO
[3]  
2-4
[4]   COMPARING THE MEANS OF SEVERAL GROUPS [J].
GODFREY, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) :1450-1456
[5]  
HOSKING DJ, 1981, Q J MED, V50, P473
[6]   MECHANISM OF THE HYPOCALCEMIC EFFECT OF MITHRAMYCIN [J].
KIANG, DT ;
LOKEN, MK ;
KENNEDY, BJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (02) :341-344
[7]   CIS-PLATINUM TREATMENT FOR MALIGNANCY-ASSOCIATED HUMORAL HYPERCALCEMIA IN AN ATHYMIC MOUSE MODEL [J].
KUKLA, LJ ;
ABRAMSON, EC ;
MCGUIRE, WP ;
SHEVRIN, DH ;
LAD, T ;
KUKREJA, SC .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (05) :559-562
[8]   FAILURE OF TOTAL CALCIUM CORRECTED FOR PROTEIN, ALBUMIN, AND PH TO CORRECTLY ASSESS FREE CALCIUM STATUS [J].
LADENSON, JH ;
LEWIS, JW ;
BOYD, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 46 (06) :986-993
[9]  
MOERTELL CG, 1986, CANCER, V38, P388
[10]   COMPARATIVE-STUDY OF AVAILABLE MEDICAL THERAPY FOR HYPERCALCEMIA OF MALIGNANCY [J].
MUNDY, GR ;
WILKINSON, R ;
HEATH, DA .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (03) :421-432